Synbio Tech's Innovative Probiotic Approach Revitalizes Gut and Vaginal Microbiota in Pregnant Women with Candidiasis

January 31, 2024 12:00 PM AEDT | By Cision

Synbio Tech's Innovative Probiotic Approach Revitalizes Gut and Vaginal Microbiota in Pregnant Women with Candidiasis — Image source: Kalkine Media

Recent News

What to make of the U.S.-Ukraine minerals deal

Bloom Energy upgraded, Mizuho sees upside ahead

Regions Helps Nonprofits Tell Their Stories

Direct Relief Accepts 2025 Seoul Peace Prize for Global Humanitarian I...

KAOHSIUNG, Jan. 31, 2024 /PRNewswire/ -- Innovative research and proprietary technologies have placed Synbio Tech, Inc. (1295:TT) at the forefront of the probiotics field. The company's advancements not only enhance probiotic production efficiency but also significantly benefit intestinal health, aligning with the rising global demand for probiotics. Synbio Tech's ongoing innovations, underscored by its plan to build a new manufacturing facility in Kaohsiung Science Park, reaffirm its growing influence in the expanding global probiotic market. According to Mordor Intelligence, this market is expected to grow from US$73.377 billion in 2023 to US$105.49 billion by 2028, highlighting the increasing relevance of probiotics in health and nutrition. Recently, the spotlight has been on the potential of probiotics in women's health, a sector ripe for market growth. Synbio Tech is poised to be a key player in this arena, especially with its groundbreaking probiotic product SynForU™-HerCare for vaginal candidiasis. This latest research marks a significant stride in maternal healthcare, offering promising benefits for the health and well-being of pregnant women.

Synbio Tech's recent study reveals that their SynForU-HerCare probiotic effectively reduces vaginal candidiasis in pregnant women. This common condition during pregnancy can impact both mother and baby's health. The study shows that SynForU-HerCare, by suppressing harmful bacteria like Prevotella and Atopobium and boosting beneficial Lactobacillus, helps maintain a healthy balance of intestinal and vaginal flora. This probiotic also supports diverse gut bacteria and Firmicutes, crucial for nutrient absorption, protection, and immune function. These findings offer a non-invasive way to enhance microbiome health during pregnancy, marking a significant advancement in women's health. Synbio Tech's innovation in this area underscores their commitment to advanced probiotic applications and women's health programs.

Moreover, Synbio Tech's continued investment in the research and development of new products serves to emphasize its ongoing commitment to innovation in the field of women's health. On the basis of its scientific research, the company is committed to addressing the health-related challenges that women face at different stages of life, and looks forward to introducing further innovative health solutions in the future. These efforts not only demonstrate the company's expertise in women's healthcare but also its long-term commitment to improving women's health worldwide.

Reference:
Lactobacillus probiotics restore vaginal and gut microbiota of pregnant women with vaginal candidiasis
Probiotics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.